Gamibetal / Buxamine

Ingredients:

Syrup: 100 ml contains: Active Ingredient: 10 g buxamine (gamma amino beta-hydroxy butyric acid). Other Ingredients: sucrose, sodium methyl p-hydroxybenzoate, sodium metabisulphite, sodium propyl p-hydroxybenzoate, sodium edetate, apricot essence, alcohol, purified water.

Tablets:

1 tablet contains: Active Ingredient: 500 mg buxamine (gamma amino beta-hydroxy butyric acid). Other Ingredients: Cornstarch, gelatin, magnesium stearate.

Pharmaceutical category:

Anti-epileptic.

Recommended for treating: Idiopathic and symptomatic epilepsy and all types of convulsions.

Contraindications:

Known individual hypersensitivity to this product.

Caution:

During treatment with barbiturates and other anti-epileptic drugs, the initial dosage of GAMIBETAL should be gradually increased while at the same time gradually withdrawing the dosage of the pharmaceutical drug used previously.

Pregnant women should only take this product when absolutely necessary and always under a physician’s supervision.

Interactions:

No adverse interactions of any type have been reported.

Warning:

This syrup contains sodium metabisulphite. This substance may cause allergic reactions and serious asthmatic attacks in sensitive patients and particularly in asthma sufferers.

Dosage and directions for use:

500 mg. tablets: 2-6 tablets, according to your physician’s directions.

Syrup 10%: 1-4 small doses daily according to your physician’s directions.

When treating elderly patients, the physician must closely monitor this dosage and assess the possibility of a gradual reduction of it.

Instructions for opening and closing the phial:

To open the phial: Unscrew the cap and turn until it stops. Then hold the phial as shown in Fig 1 and push the cap upwards. To close the phial: Place the cap over the mouth of the phial as shown in Fig 2. Then press down until it is closed tight.

Overdose:

No symptoms of overdose of this product have been reported.

Side effects:

In some cases GAMIBETAL can cause temporary anorexia and drowsiness.

Expiry: Do not take this drug after the expiry date shown on the container.

KEEP OUT OF THE REACH OF CHILDREN

Disclaimer: This product and its statements have not been evaluated by the FDA. This product is not intended to treat, cure or prevent any disease.

The above information is the translation of the manufacturer's insert. It is provided under the supplying company's terms and conditions and should not replace the advice of your personal physician.


The above information is the translation of the manufacturer's insert. It is provided under the supplying company's terms and conditions and should not replace the advice of your personal physician.

Related products